Galle P et al. Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology front wo randomised, placebo-controlled phase 3 studies (REACH-2 and REACH). (Abstract GS-09)
ISHAM 2022 - Schimmels en gisten wereldwijd in zorgwekkende opmars
okt 2022 | Schimmelinfecties